| Not Yet Recruiting | A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 1 NCT07124559 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 / Phase 2 |
| Not Yet Recruiting | Diagnostic Performance and Safety of Endobronchial Ultrasound-guided Transbronchial Mediastinal Cryobiopsy in NCT07459569 | China-Japan Friendship Hospital | N/A |
| Not Yet Recruiting | A Home-Based Approach to Tuberculosis Preventive Treatment Management NCT07479030 | Dilla University | N/A |
| Not Yet Recruiting | STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis NCT07332325 | University of Virginia | Phase 3 |
| Not Yet Recruiting | Development of a Clinical-epidemiological Score Predictive of Tuberculosis. NCT07485868 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda NCT05917210 | Yale University | N/A |
| Not Yet Recruiting | Evaluation and Demonstration of New Tuberculosis Diagnostics for Indonesia NCT07293455 | Universitas Padjadjaran | N/A |
| Not Yet Recruiting | Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of N NCT07386912 | Research Center Borstel | — |
| Recruiting | Quantitative Measurement of Plasma and Urine MTB Cell-free DNA Level NCT07170735 | Chinese University of Hong Kong | — |
| Recruiting | Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in Tuberculosis NCT07484490 | Riphah International University | N/A |
| Not Yet Recruiting | Evaluation of PATHFAST-LAM as a Tuberculosis Treatment Monitoring Tool in Kenya NCT07157904 | Nagasaki University | — |
| Not Yet Recruiting | A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery NCT07136987 | Open Source Pharma Foundation | Phase 3 |
| Withdrawn | Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living Wit NCT05539989 | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | Phase 1 / Phase 2 |
| Not Yet Recruiting | Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese C NCT07268664 | Beijing Chest Hospital | Phase 3 |
| Not Yet Recruiting | Hospital and Extra-hospital Nursing Care for Tuberculosis NCT06696053 | Assistance Publique - Hôpitaux de Paris | N/A |
| Withdrawn | Safety and Challenge Study of BCG TICE(R) Vaccination to Test Tuberculosis Immunity in Heathy Humans NCT06845358 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Recruiting | Candidate Clinical Correlate of Prognostic Outcome for TB Study NCT07018076 | University of California, San Francisco | — |
| Recruiting | Asymptomatic TB With Innovative Modified Short-course Regimens NCT06153069 | Huashan Hospital | Phase 4 |
| Recruiting | A Study to Evaluate the Safety and Immunogenicity of Ad5-105K in Adults Aged 18 to 49 Years NCT06732583 | CanSino Biologics Inc. | Phase 1 |
| Recruiting | Window Prophylaxis for Pediatric Tuberculosis Prevention Trial NCT07086820 | Pontificia Universidad Catolica de Chile | N/A |
| Recruiting | Precision Rifampin Trial for Personalized Dosing NCT06318416 | University of Virginia | Phase 1 |
| Recruiting | A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets NCT07170800 | WestVac Biopharma Co., Ltd. | Phase 2 |
| Recruiting | Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatmen NCT06497465 | Johns Hopkins University | Phase 3 |
| Not Yet Recruiting | Evaluating Next Generation LAM Assays and Molecular Diagnostics (POC and Near POC) for the Diagnosis of TB Amo NCT06019052 | Foundation for Innovative New Diagnostics, Switzerland | — |
| Not Yet Recruiting | Scalable Public Health Empowerment, Research, and Education Sites (SPHERES) NCT07126041 | Oxford University Clinical Research Unit Indonesia | N/A |
| Recruiting | Questioning the Epidemiology of Asymptomatic TB NCT07312266 | Barcelona Institute for Global Health | — |
| Recruiting | Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infe NCT07152639 | Chengdu CoenBiotech Co., Ltd | Phase 3 |
| Not Yet Recruiting | Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early NCT07118059 | North-West University, South Africa | Phase 2 |
| Active Not Recruiting | Digitally Facilitated, Integrated Community and Facility-Based Interventions: The HEART-TB Trial Protocol NCT07440160 | Arba Minch University | N/A |
| Recruiting | Sputum-free Diagnostis of TB NCT07125274 | Research Center Borstel | — |
| Not Yet Recruiting | Prospective Cohort of People Starting Treatment for Tuberculosis Disease in France (FrenchTB) NCT06893757 | ANRS, Emerging Infectious Diseases | — |
| Not Yet Recruiting | Development of the Drug and Alcohol Respiratory Health Test NCT06921278 | King's College London | — |
| Recruiting | A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide NCT06748937 | TASK Applied Science | Phase 2 |
| Completed | Start Taking Action For TB Diagnosis NCT05845112 | Liverpool School of Tropical Medicine | — |
| Recruiting | LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea NCT06946784 | Yonsei University | — |
| Enrolling By Invitation | Systems Analysis and Improvement Approach to Prevent TB NCT06314386 | Boston College | N/A |
| Recruiting | Shortened Regimen for Drug-susceptible TB in Children NCT06253715 | Johns Hopkins University | Phase 3 |
| Active Not Recruiting | ID93/GLA-SE Vaccination + BCG Challenge NCT06670755 | University of Oxford | N/A |
| Not Yet Recruiting | Immunocompetent Versus Immunocompromised Tuberculosis (TB) Patients NCT06709157 | Sohag University | — |
| Active Not Recruiting | Alternative Diagnoses in Patients About to Start Empiric Tuberculosis Treatment NCT06737029 | Stichting Longartsen voor Afrika | — |
| Not Yet Recruiting | Multidrug Resistance in Newly Diagnosed TB Patient NCT06700577 | Assiut University | — |
| Not Yet Recruiting | Detection of Lipoarabinomannan in Urine Evaluation of the STANDARDTMF TBLAMFIA and Its Impact on the Initial T NCT06306430 | Ospedale San Raffaele | — |
| Enrolling By Invitation | Detection of Mycobacterium Tuberculosis in Blood of TB Patients and Their Contacts in Uganda NCT06751706 | Queen Mary University of London | — |
| Recruiting | Improving the Outcomes of Children With Tuberculosis Through Innovative Diagnostics and Treatment Monitoring NCT06815588 | Research Center Borstel | — |
| Completed | Post-Trial Tuberculosis Case Finding: A Substudy of CoVPN 3008 NCT06585683 | COVID-19 Prevention Network | — |
| Recruiting | Lung Innate Immunity and Microbiome After Tuberculosis Exposure NCT06526689 | University of Oxford | — |
| Recruiting | Clinical Evaluation of an IGRA Test for the Diagnosis of Active and Latent Tuberculosis NCT06485895 | Assistance Publique Hopitaux De Marseille | N/A |
| Suspended | BCG Revaccination in Children and Adolescents NCT05330884 | Tuberculosis Research Centre, India | Phase 3 |
| Completed | Evaluating the Accuracy of New Tests for TB Infection Diagnosis NCT06221735 | Freundeskreis Für Internationale Tuberkulosehilfe e.V | N/A |
| Recruiting | Increased Tuberculosis Case Detection - DiOpTB NCT06437184 | Aarhus University Hospital | N/A |
| Recruiting | Assessing the Feasibility of Coach Mpilo for Men With TB and HIV NCT07117370 | Arizona State University | N/A |
| Not Yet Recruiting | Study of GeneXpert Mycobacterium Tuberculosis/ Rifampicin (MTB/RIF) Versus the Routine Methods for Detection o NCT06409572 | Sohag University | — |
| Recruiting | The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis NCT06593080 | Chishala Chabala | N/A |
| Completed | Evaluation of CAD-based Triage for CXR Interpretation During TB Screening NCT06401434 | Freundeskreis Für Internationale Tuberkulosehilfe e.V | N/A |
| Completed | Targeted Universal TB Testing With Simultaneous TPT Prescribing Among People Living With HIV in South Africa NCT06739915 | Johns Hopkins University | N/A |
| Recruiting | Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality NCT06338215 | Clinica Universidad de Navarra, Universidad de Navarra | N/A |
| Not Yet Recruiting | TB Case-Finding, Treatment and Prevention Intervention in Thailand NCT05581212 | Institut de Recherche pour le Developpement | N/A |
| Completed | Single-Dose Study to Evaluate the PKs of Pretomanid in Participants With Renal Impairment Compared to Particip NCT03896750 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Recruiting | Diagnostic Innovations for Pediatric Tuberculosis in Bolivia NCT06113861 | Tulane University | — |
| Completed | A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combinati NCT06354257 | GlaxoSmithKline | Phase 1 |
| Enrolling By Invitation | BCG Revaccination Study in Diabetic and Non-Diabetic Adults NCT06246851 | University of Oxford | N/A |
| Recruiting | Mediastinal EBUS Cryobiopsy Study In Sweden NCT06347939 | Region Skane | — |
| Completed | Cali Sin Tos Aim 2 NCT06338462 | Yale University | N/A |
| Recruiting | South Africa Smoking Cessation and Engagement in HIV/TB Care Care NCT05842161 | Massachusetts General Hospital | N/A |
| Recruiting | Silicosis and Silicotuberculosis Among Small Scale Gemstone Miners in Northern Tanzania NCT06403800 | National Heart and Lung Institute | — |
| Active Not Recruiting | Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and NCT06062238 | Gates Medical Research Institute | Phase 3 |
| Unknown | A Controlled Human Infection Model (CHIM) With Intradermal BCG in Malawi NCT06178666 | Liverpool School of Tropical Medicine | N/A |
| Completed | ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa NCT06214910 | University of Washington | N/A |
| Enrolling By Invitation | Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis NCT06811025 | Beijing Chest Hospital | Phase 1 / Phase 2 |
| Enrolling By Invitation | Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis NCT06811012 | Beijing Chest Hospital | Phase 1 / Phase 2 |
| Recruiting | Evaluating the Safety and Immunogenicity of MTBVAC NCT05947890 | HIV Vaccine Trials Network | Phase 2 |
| Recruiting | Rapid Research in Diagnostics Development for TB Network (R2D2 Kids) and Assessing Diagnostics At POC for TB i NCT05989802 | University of California, San Francisco | N/A |
| Completed | Tuberculosis Vaccine in Healthy Indian Adults NCT06438978 | Bharat Biotech International Limited | Phase 1 |
| Recruiting | Testing Health Workers At Risk to Advance Our Understanding of TB Infection NCT06221488 | Beth Israel Deaconess Medical Center | — |
| Recruiting | MoMa Signature During Granulomatosis NCT05916638 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | ATORvastatin in Pulmonary TUBerculosis NCT06199921 | Obafemi Awolowo University Teaching Hospital | Phase 2 |
| Completed | Delivering a Multi-disease Screening Tool to Migrant Populations NCT05868005 | Barcelona Institute for Global Health | N/A |
| Completed | Phase 2 Study of the ТВ/Flu-05Е Tuberculosis Vaccine NCT06873282 | Research Institute of Influenza, Russia | Phase 2 |
| Unknown | Sensitivity and Specificity of Xpert MTB/RIF Ultra NCT06058065 | Assiut University | — |
| Unknown | "Conducting A Study On Video Observed Therapy In The Management Of Tuberculosis" NCT05994144 | University of Malaya | N/A |
| Unknown | Clinical Presentation, and Treatment Outcomes in Tuberculous Patients in Sohag Governorate NCT06141148 | Sohag University | — |
| Recruiting | Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resi NCT05586230 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Recruiting | DRug Use & Infections in ViEtnam: TuBerculosis Control NCT05655702 | ANRS, Emerging Infectious Diseases | N/A |
| Completed | Evaluating the Potential of Large Language Models for Respiratory Disease Consultations NCT06457269 | North Sichuan Medical College | N/A |
| Not Yet Recruiting | KAP Regarding Tuberculosis Among Physicians in Assiut City NCT05805878 | Assiut University | — |
| Completed | Endurance Training in Patients With Post-TB Lung Disease NCT06047795 | Riphah International University | N/A |
| Recruiting | Impact Evaluation of Use of MATCH AI Predictive Modelling for Identification of Hotspots for TB Active Case Fi NCT06017843 | Centre for Global Public Health Pakistan | N/A |
| Recruiting | TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts NCT06022146 | Huashan Hospital | Phase 3 |
| Recruiting | Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients NCT06033807 | Huashan Hospital | — |
| Recruiting | Assessing Diagnostics At Point-of-care for Tuberculosis NCT05941052 | University of California, San Francisco | N/A |
| Completed | Using SMS Reminders, Phone Calls and Money Incentives to Enhance Linkage to Care of Presumptive TB Patients in NCT05964842 | Makerere University | N/A |
| Unknown | A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pul NCT05575518 | Stellah Mpagama | Phase 3 |
| Active Not Recruiting | Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis NCT05547464 | BioNTech SE | Phase 1 / Phase 2 |
| Active Not Recruiting | A Pan-TB Regimen Targeting Host and Microbe NCT05686356 | The Aurum Institute NPC | Phase 2 / Phase 3 |
| Completed | Phase II Clinical Clical of the Pure Protein Derivatives of BCG NCT06975774 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Phase 1 |
| Active Not Recruiting | Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifape NCT05118490 | The Aurum Institute NPC | Phase 4 |
| Unknown | Clinical Trial to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Pre NCT06305104 | Chengdu CoenBiotech Co., Ltd | Phase 2 |
| Recruiting | Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service NCT05342064 | Baylor College of Medicine | N/A |
| Unknown | Using BCG Vaccine to Understand Tuberculosis Infection NCT05820594 | Liverpool School of Tropical Medicine | N/A |
| Completed | Isoniazid Prophylaxis Based on Risk Factors of Tuberculosis in Living Kidney Transplantation Recipients NCT06512831 | West China Hospital | N/A |
| Recruiting | Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis NCT06403943 | Beijing Chest Hospital | Phase 4 |
| Active Not Recruiting | Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Tr NCT05122767 | The Aurum Institute NPC | Phase 1 / Phase 2 |
| Recruiting | Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberc NCT05473520 | National University Hospital, Singapore | Phase 3 |
| Completed | Biodistribution and Pharmacokinetics of Pretomanid in Tuberculosis Patients Using 18F-Pretomanid PET NCT05609552 | Johns Hopkins University | — |
| Completed | Evaluation of Tuberculosis Treatment Outcomes NCT06942975 | Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria | — |
| Completed | Frequency of Tuberculosis in Psoriasis Patients NCT06563635 | Bezmialem Vakif University | — |
| Unknown | Active Close Contact Investigation of Tuberculosis Through Computer-aided Detection and Stool Xpert MTB/RIF Am NCT05818059 | Doctors with Africa - CUAMM | N/A |
| Recruiting | Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis ( NCT05534750 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Completed | Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis NCT05537038 | BioNTech SE | Phase 1 |
| Recruiting | Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients NCT05571735 | University of Oxford | — |
| Unknown | Pulmonary Rehabilitation in Non-chronic Obstructive Pulmonary Disease Patients. NCT05174741 | Riphah International University | N/A |
| Suspended | Effectiveness and Cost-Effectiveness of Depression Treatment for Individuals With TB in South Africa NCT05091580 | New York State Psychiatric Institute | N/A |
| Completed | Safety, Tolerability, Pharmacokinetics (PK), and Food Effect of MK-7762 in Healthy Adults NCT05824091 | Gates Medical Research Institute | Phase 1 |
| Completed | Zinc and Selenium Bioactivity NCT07180329 | University of Lahore | N/A |
| Completed | Phase I Clinical Trial to Evaluate the Safety of Recombinant Mycobacterium Tuberculosis Fusion Protein (EEC) i NCT06224608 | Chengdu CoenBiotech Co., Ltd | Phase 1 |
| Unknown | Relevance of Isoniazid Dosage in Adults Treated for Tuberculosis NCT06054334 | Centre Hospitalier Universitaire, Amiens | — |
| Completed | Diagnosis Test of Real-time Polymerase Chain Reaction (RT-PCR) for Pulmonary Tuberculosis NCT06284187 | Khon Kaen Hospital | — |
| Recruiting | Mycobacteria Registry Study: Prospective Observational Study in Austria NCT06522347 | Ludwig Boltzmann Institute for Lung Health | — |
| Completed | Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines NCT05592223 | Fred Hutchinson Cancer Center | Phase 1 |
| Completed | Comparison of Three Different Puncture Techniques in EBUS-TBNA NCT05628454 | Beijing Friendship Hospital | N/A |
| Recruiting | Gene Expression Profiles in Spinal Tuberculosis. NCT05610098 | University of Cape Town | — |
| Recruiting | Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa NCT04975178 | Biofabri, S.L | Phase 3 |
| Recruiting | Alcohol Reduction Among People With TB and HIV in India NCT04230395 | Johns Hopkins University | N/A |
| Unknown | Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled T NCT05738681 | Mahidol University | Phase 2 / Phase 3 |
| Completed | Tuberculosis Diagnostic Trial of CAD4TB Screening Alone Compared to CAD4TB Screening Combined With a CRP Triag NCT05526885 | Klaus Reither | N/A |
| Completed | TB-CAPT EXULTANT - HIV NCT04568967 | Foundation for Innovative New Diagnostics, Switzerland | N/A |
| Unknown | Latent Tuberculosis in Healthcare Workers - the Reality of a Portuguese Tertiary Hospital NCT05847491 | Centro Hospitalar do Oeste | — |
| Completed | TB-CAPT CORE Truenat Trial NCT04568954 | Foundation for Innovative New Diagnostics, Switzerland | N/A |
| Recruiting | Safety of Administering Isoniazid to SLE Patients to Prevent TB NCT06618573 | Universitas Padjadjaran | Phase 2 / Phase 3 |
| Active Not Recruiting | Linezolid Dosing Strategies in Drug-Resistant TB NCT05007821 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Est NCT05382312 | GlaxoSmithKline | Phase 2 |
| Recruiting | A Systemic Screening for TB Disease in High-risk Groups in Barcelona NCT06706596 | Fundació Institut Germans Trias i Pujol | — |
| Completed | Effect of Integrating Traditional Tuberculosis Care With Modern Health Care on Case Detection NCT05236452 | Bahir Dar University | N/A |
| Unknown | Oral Vitamin D and Toll Like Receptor in Spondylitis Tuberculosis NCT05376189 | Hasanuddin University | Phase 2 / Phase 3 |
| Completed | A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults NCT05526911 | Global Alliance for TB Drug Development | Phase 1 |
| Active Not Recruiting | Host Blood RNA Signatures for Diagnosis of TB NCT05542511 | University of Stellenbosch | — |
| Unknown | Preventive Treatment Of Latent Tuberculosis Infection In People With Diabetes Mellitus NCT04600167 | Dr. Nyanda Elias Ntinginya | Phase 3 |
| Completed | Community Health Worker Training to Reduce Depression and Substance Use Stigma in TB/HIV Care in South Africa NCT05282173 | University of Maryland, College Park | N/A |
| Unknown | Effectiveness Of Mobile Application To Improve Adherence To Tuberculosis Treatment NCT05259254 | Mohd Fazeli bin Sazali | N/A |
| Unknown | Endobronchial Ultrasound Needle Aspiration With and Without Suction NCT05110950 | Università Politecnica delle Marche | N/A |
| Completed | Triage Test for All Oral DR-TB Regimen (TRiAD Study) NCT05175794 | Centre for the AIDS Programme of Research in South Africa | — |
| Completed | Aerosol BCG Challenge Study in Historically BCG-vaccinated Volunteers NCT04777721 | University of Oxford | Phase 1 |
| Completed | Whole Genome Sequencing of Tuberculosis for Disease Control in Madagascar NCT05406453 | Institut Pasteur de Madagascar | N/A |
| Completed | Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Supp NCT04738812 | ANRS, Emerging Infectious Diseases | Phase 3 |
| Recruiting | Cough Audio Classification as a TB Triage Test NCT05317247 | University of Stellenbosch | — |
| Recruiting | My Mobile Wallet: An Intervention for Tuberculosis Medication Adherence in Rural Uganda NCT05656287 | Mbarara University of Science and Technology | N/A |
| Unknown | The Prophylaxis of Tuberculosis According to TSPOT Results After Kidney Transplantation NCT05249699 | West China Hospital | N/A |
| Completed | Ultra Curto (Ultra Short) TB Prevention Therapy NCT04703075 | Johns Hopkins University | Phase 4 |
| Completed | Human-centered Design and Communities of Practice to Improve Home-based Tuberculosis Contact Investigation in NCT05640648 | Yale University | N/A |
| Completed | Health and Migration Trajectories of Housekeepers in Bamako NCT05472051 | ANRS, Emerging Infectious Diseases | — |
| Completed | A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China NCT05337163 | Creative Biosciences (Guangzhou) Co., Ltd. | — |
| Active Not Recruiting | Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated NCT05220163 | University of Cape Town | N/A |
| Suspended | A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02) NCT05284812 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Phase 2 |
| Unknown | A Trial of Radial EBUS Versus VBN for the Peripheral Pulmonary Lesions NCT05739695 | Ilya Sivokozov | N/A |
| Unknown | Tuberculosis Drug Levels and Continuous Glucose Monitoring in Diabetic Patients NCT05329415 | London North West Healthcare NHS Trust | — |
| Unknown | Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac NCT04975737 | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Phase 3 |
| Active Not Recruiting | Pharmacokinetics of Drugs Used to Treat Drug Sensitive Tuberculosis in Breastfeeding Mother-infant Pairs NCT05840809 | University of Liverpool | — |
| Unknown | Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa NCT04618198 | University of Virginia | Phase 3 |
| Unknown | Pharmacogenetics-guided Isoniazid Dosing in TB-HIV NCT05124678 | Makerere University | Phase 2 |
| Active Not Recruiting | eNose-TB: Electronic Nose for Tuberculosis Screening NCT04567498 | Gadjah Mada University | N/A |
| Unknown | Utilizing the Crosstalk Among Chicoric Acid, 13-Cis Retinoic Acid(Aerosolized), Minocycline and Vitamin D as a NCT05077813 | Kafrelsheikh University | Phase 2 |
| Withdrawn | Evaluation of Efficacy and Safety of the Concomitant of RUTI® Immunotherapy With the Standard Treatment in TB NCT05136833 | Archivel Farma S.L. | Phase 2 |
| Completed | Evaluating a New Stool Based qPCR for Diagnosis of Tuberculosis in Children and People Living With HIV NCT05047315 | Barcelona Institute for Global Health | — |
| Unknown | Randomized Clinical Trial: IS Zinc and Zinc Ionophere EGCG as Supplement Improve Outcome of Active Pulmonary T NCT05116098 | Ministry of Health, Saudi Arabia | Phase 1 |
| Completed | Specificity Trial of the Recombinant Tuberculosis Allergen in BCG Vaccinated Healthy Volunteers NCT05203068 | National Medical Research Center of Phthisiopulmonology and Infectious Diseases | N/A |
| Completed | Validation of Artificial Intelligence Enabled TB Screening and Diagnosis in Zambia NCT05139940 | Centre for Infectious Disease Research in Zambia | — |
| Completed | Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin NCT04166474 | Helen Reynolds | Phase 4 |
| Recruiting | Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students NCT05756582 | Eleonora Nucera | — |
| Completed | Impact of Malnutrition on Pharmacokinetic of Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV Co-i NCT04972903 | Institut National de la Santé Et de la Recherche Médicale, France | — |
| Terminated | Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CL NCT04311502 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Dried Blood Spot Test to Assess TB in Pregnancy NCT04871230 | Institut Pasteur de Madagascar | — |
| Completed | Interrupting HIV and TB Stigma in the Household in Uganda NCT05124665 | Yale University | N/A |
| Completed | Triage UltraSound in Tb Endemic Regions NCT05423847 | Centre Hospitalier Universitaire Vaudois | — |
| Completed | Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment NCT04874948 | Michael Hoelscher | Phase 1 |
| Completed | Airborne Preventive Measures to Reduce New TB Infections in Household Contacts NCT04938596 | Pontificia Universidad Catolica de Chile | N/A |
| Completed | Improved Diagnostics for Paediatric Tuberculosis NCT06944561 | St George's, University of London | N/A |
| Completed | Inpatient Package to Reduce HIV and AIDS-related Death in Zambia NCT04033718 | University of Alabama at Birmingham | N/A |
| Completed | A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant NCT04179500 | Global Alliance for TB Drug Development | Phase 2 |
| Completed | Acoustic Cough Monitoring for the Management of Patients With Known Respiratory Disease NCT05042063 | Clinica Universidad de Navarra, Universidad de Navarra | — |
| Completed | Prevent TB: Choice Architecture for TPT Delivery NCT04466488 | Johns Hopkins University | N/A |
| Completed | Community Initiated Preventive Therapy for TB NCT04369326 | Johns Hopkins University | N/A |
| Completed | TB and Sarcoidosis Granuloma NCT06396910 | Karolinska Institutet | — |
| Completed | Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum NCT04518228 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) NCT04930744 | University of Massachusetts, Worcester | Phase 2 |
| Completed | Potential Role of Microbiome in Tuberculosis NCT04985994 | Khyber Medical University Peshawar | — |
| Unknown | Pharmacokinetics of Twice or Once Daily DTG (50mg) in Children With HIV and TB NCT04746547 | University of KwaZulu | Phase 4 |
| Active Not Recruiting | PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral NCT04926922 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Terminated | A Real-world Study of Tuberculosis Incidence in AS, PsA, or PsO Patients Treated With Secukinumab in Brazil NCT06715254 | Novartis Pharmaceuticals | — |
| Active Not Recruiting | Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis Patients NCT04538911 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Phase 1 |
| Unknown | Vitamin D Supplementation and TB NCT01992263 | Cornell University | N/A |
| Active Not Recruiting | TB-CAPT MTB/XDR Study NCT04567368 | Foundation for Innovative New Diagnostics, Switzerland | — |
| Withdrawn | A Study of the Pharmacokinetic and Pharmacodynamic Interactions Between Bictegravir, Tenofovir Alafenamide and NCT04551573 | Yale University | Phase 4 |
| Unknown | Tuberculosis Drug Levels in Diabetics NCT04242511 | London North West Healthcare NHS Trust | — |
| Completed | Transmission of Tuberculosis Among Illicit Drug Use Linkages NCT04151602 | Boston Medical Center | — |
| Completed | Predicting the Future: Incipient Tuberculosis NCT04825327 | Amsterdam Institute for Global Health and Development | — |
| Recruiting | Rapid Research in Diagnostics Development for TB Network NCT04923958 | University of California, San Francisco | N/A |
| Completed | New Reusable Mask Design With Superior Filtration and Fit NCT04826809 | Mayo Clinic | N/A |
| Unknown | Rifampicin at High Dose for Difficult-to-Treat Tuberculosis NCT04768231 | Hospital Universitari Vall d'Hebron Research Institute | Phase 2 |
| Completed | Choice Architecture Based TB Preventive Therapy Prescribing NCT04466293 | Johns Hopkins University | N/A |
| Active Not Recruiting | Xpert Active Case-finding Trial 3 (XACT-3) NCT04303104 | University of Cape Town | N/A |
| Completed | Tuberculosis as a Risk Factor for a Worse Outcome Post-Sars-CoV-2 Infection NCT05643781 | The Aurum Institute NPC | — |
| Completed | Prevalence and Malignant Involvement of Calcified Intrathoracic Lymph Nodes in Patients Undergoing Endosonogra NCT04743583 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Novel Triple-dose Tuberculosis Retreatment Regimen NCT04260477 | Institute of Tropical Medicine, Belgium | Phase 3 |
| Unknown | Early Risk Assessment in Household Contacts (≥10 Years) of TB Patients by New Diagnostic Tests in 3 African Co NCT04781257 | Michael Hoelscher | — |
| Completed | Accessibility of the World Health Organization's eTB Catalogue of Recommendations NCT04745897 | McMaster University | N/A |
| Completed | Study to Evaluate Safety, Tolerability, and the PK Profile of TBI-223 in Healthy Subjects NCT04865536 | Global Alliance for TB Drug Development | Phase 1 |
| Unknown | Development of Molecular Diagnostic Platform for Tuberculosis NCT04734236 | Asan Medical Center | N/A |
| Completed | Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculo NCT04721795 | Obafemi Awolowo University Teaching Hospital | Phase 2 / Phase 3 |
| Completed | TB PCR in BAL and EBUS-TBNA NCT04909385 | Imperial College Healthcare NHS Trust | — |
| Completed | Phenotyping of High Dose Rifampicin NCT04525235 | Radboud University Medical Center | Phase 1 |
| Unknown | Cyclophosphamide in the Treatment of Refractory Proliferative Arachnoiditis in CNS Tuberculosis NCT04620772 | All India Institute of Medical Sciences | Phase 2 / Phase 3 |
| Unknown | Impact of the Respiratory Isolation on the Quality of Life in Patients Hospitalized for Tuberculosis or COVID- NCT04677478 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Evaluation of the Safety, Tolerability, PK of TBAJ-587 in Healthy Adults NCT04890535 | Global Alliance for TB Drug Development | Phase 1 |
| Unknown | Influence of Filarial Infections on Tuberculosis Disease and Tuberculosis Vaccination in Cameroon NCT04547738 | University Hospital, Bonn | — |
| Active Not Recruiting | TB Treatment Support Tool Interactive Mobile App and Direct Adherence Monitoring on TB Treatment Outcomes NCT04221789 | Institute for Clinical Effectiveness and Health Policy | N/A |
| Active Not Recruiting | TB Screening Improves Preventive Therapy Uptake NCT04557176 | University of California, San Francisco | N/A |
| Unknown | Point-of-care Triage Test for Active Tuberculosis NCT04232618 | University of Stellenbosch | — |
| Unknown | Efficacy of 400 mg Efavirenz Versus Standard 600 mg Dose in HIV/TB Co-infected Patients NCT04513379 | Shanghai Public Health Clinical Center | Phase 3 |
| Terminated | A Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2556286 in Healthy Adult Participants NCT04472897 | GlaxoSmithKline | Phase 1 |
| Completed | Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Posi NCT04121195 | University of Liverpool | Phase 2 / Phase 3 |
| Completed | A Clinical Trial of the Safety, Pharmacokinetics and Hematologic Effects of Imatinib on Myelopoiesis in Adults NCT03891901 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Clinical Study of BCG Vaccine for Intradermal Injection NCT04563273 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Phase 1 |
| Completed | Phase I Clinical Protocol of BCG-PPD in Healthy People NCT04593771 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Phase 1 |
| Unknown | Impact of Mobile Health Interactive Software on Tuberculosis Outcomes; The Call for Life (CFLU-TB) Project NCT04709159 | Makerere University | N/A |
| Unknown | TB-LAM in the Diagnosis of TB NCT04600232 | Shanghai Public Health Clinical Center | N/A |
| Unknown | Identifcation of Biomarkers for Active Pulmonary Tuberculosis NCT04490746 | Second Affiliated Hospital, School of Medicine, Zhejiang University | — |
| Completed | Rifampin and the Contraceptive Implant NCT04463680 | University of Colorado, Denver | Phase 4 |
| Completed | Kharituwe TB Contact Tracing Study NCT04520113 | Johns Hopkins Bloomberg School of Public Health | N/A |
| Completed | Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PT NCT04629378 | TASK Applied Science | Phase 2 |
| Recruiting | The Role of a Mycobacterium Growth Inhibition Assay to Quantify Host Immune Control of M. Tuberculosis NCT06580639 | Linkoeping University | — |
| Active Not Recruiting | The Impact of Malnutrition on Immune Responses to Tuberculosis NCT05044910 | Tuberculosis Research Centre, India | — |
| Unknown | Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis NCT04545788 | Beijing Chest Hospital | N/A |
| Completed | DOT Selfie: A Mobile Technology Intervention to Evaluate Treatment Adherence Among Tuberculosis Patients NCT04134689 | University of Georgia | N/A |
| Completed | Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention (3HP Options Implementation Trial) NCT03934931 | University of California, San Francisco | N/A |
| Unknown | SMS-based Mobile Health Intervention for Nutritional Status and Treatment Outcome Among TB Patients NCT04242472 | Addis Ababa University | N/A |
| Completed | Increasing Notifications of Tuberculosis From Private Practitioners NCT04187313 | Universitas Padjadjaran | N/A |
| Completed | Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults NCT04493671 | Global Alliance for TB Drug Development | Phase 1 |
| Completed | Electronic Pillbox-enabled SAT Versus DOT for TB Medication Adherence and Treatment Outcomes NCT04216420 | Addis Ababa University | N/A |
| Unknown | Pharmacokinetic Evaluation and Local Tolerability of Dry Powder Amikacin Via the Cyclops™ NCT04249531 | University Medical Center Groningen | Phase 1 |
| Completed | A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02) NCT04239313 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Phase 1 |
| Unknown | Pulmonary Tuberculosis Sequelae in Patients With COPD NCT04721080 | Izmir Katip Celebi University | — |
| Completed | Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resist NCT03896685 | Médecins Sans Frontières, France | Phase 3 |
| Completed | Statin Adjunctive Therapy for TB NCT03456102 | Johns Hopkins University | Phase 2 |
| Completed | Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia NCT03915366 | Hospital Universitario 12 de Octubre | Phase 2 / Phase 3 |
| Completed | StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberc NCT03882177 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Tolerability and Reactogenicity Trial of the Recombinant Tuberculosis Allergen in Healthy Volunteers NCT05398562 | St. Petersburg Research Institute of Vaccines and Sera | Phase 1 |
| Unknown | Lowering InterLeukin-1 Receptor Antagonist Concentrations After TB Treatment Onset NCT04015713 | ANRS, Emerging Infectious Diseases | — |
| Completed | Evaluation of Four Stool Processing Methods Combined With Xpert MTB/RIF Ultra for Diagnosis of Intrathoracic P NCT04203628 | Institut National de la Santé Et de la Recherche Médicale, France | N/A |
| Recruiting | Paradoxical Tuberculosis Reactions in Patients Without HIV Infection NCT04052022 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis NCT03851588 | University of Cape Town | Phase 2 |
| Completed | Effect of Community Active Case Finding Strategies for Detection of Tuberculosis in Cambodia NCT04094350 | National University of Singapore | N/A |
| Completed | The Effect of Rifampicin on the Pharmacokinetics of Intracellular Tenofovir-diphosphate and Tenofovir When Coa NCT04424264 | Professor Francois Venter | Phase 1 |
| Completed | Patient Centered Intervention to Prevent Tuberculosis Among Children Under Five Years Old NCT03881228 | Universidad Peruana Cayetano Heredia | N/A |
| Completed | Clinical Concordance Evaluation of T-SPOT®.TB Assay Performance (T-Cell SelectTM Study) NCT04141982 | Oxford Immunotec | — |
| Completed | Development of a Diagnostic Prediction Score for Tuberculosis in Hospitalized Children With Severe Acute Malnu NCT04240990 | Institut National de la Santé Et de la Recherche Médicale, France | N/A |
| Terminated | Bacille Calmette Guerin (BCG) Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tubercu NCT04152161 | Gates Medical Research Institute | Phase 2 |
| Completed | Community-based Tuberculosis Tracing and Preventive Therapy NCT03832023 | Elizabeth Glaser Pediatric AIDS Foundation | N/A |
| Completed | Validation of a Tuberculosis Treatment Decision Algorithm in HIV-infected Children (TB-Speed HIV) NCT04121026 | Institut National de la Santé Et de la Recherche Médicale, France | N/A |
| Recruiting | Immunological Biomarkers in Tuberculosis Management NCT04271397 | Hospices Civils de Lyon | N/A |
| Completed | Assessing the Ability of the T-SPOT®.TB Test (IQ) NCT03973970 | Oxford Immunotec | — |
| Completed | Prospective Evaluation of Novel Diagnostics for Tuberculosis in KwaZulu-Natal, South Africa NCT04583904 | University of Washington | — |
| Completed | Pharmacokinetics of Atazanavir in Special Populations NCT03923231 | University of Liverpool | — |
| Completed | Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short NCT04062201 | Wits Health Consortium (Pty) Ltd | Phase 3 |
| Completed | A Study of GC3107(BCG Vaccine) in Healthy Infants NCT03947138 | Green Cross Corporation | Phase 3 |
| Completed | Usability Study of IeHS in Indonesia NCT04179344 | Bekasi City Public Hospital | — |
| Completed | Tuberculosis - Learning the Impact of Nutrition NCT03598842 | Boston Medical Center | N/A |
| Completed | Evaluation of Xpert MTB/RIF Ultra in Stools and Urine to Improve Tuberculosis Diagnosis in Children NCT06239337 | Medecins Sans Frontieres, Spain | — |
| Completed | Evaluation of Point-of-care Ultrasound in Children From 6 Months to 15 Years With Presumptive Tuberculosis NCT05364593 | Medecins Sans Frontieres, Spain | — |
| Completed | Stool Processing Kit (SPK) Evaluation for Pediatric Tuberculosis (TB) NCT04899076 | Foundation for Innovative New Diagnostics, Switzerland | — |
| Completed | Prevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART NCT03993093 | Singh, Ranjan Kumar, M.D. | — |
| Completed | Evaluation of Centralised TB Assay Solutions NCT04147676 | Foundation for Innovative New Diagnostics, Switzerland | — |
| Completed | The Role of Vitamin D, A, and Beta Carotene in Tuberculosis Patients With Vitamin D Receptor Gene Polymorphism NCT04593524 | Universitas Sumatera Utara | N/A |
| Completed | Soy, Catfish, Anchovy, and Rice Supplementation Increases 25(OH)D Serum Levels in Tuberculosis Patients With C NCT04613258 | Universitas Sumatera Utara | N/A |
| Active Not Recruiting | Nyaditum Resae® as a Co-adjuvant During Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut NCT03851159 | University of Stellenbosch | N/A |
| Completed | Integrating Pediatric TB Services Into Child Healthcare Services in Africa NCT03862261 | Elizabeth Glaser Pediatric AIDS Foundation | N/A |
| Completed | Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavi NCT03819114 | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Phase 2 |
| Completed | Clinico-radiological Classification of Peritoneal Tuberculosis NCT03927664 | Post Graduate Institute of Medical Education and Research, Chandigarh | — |
| Completed | Safety and Efficacy of High Dose Rifampicin in Tuberculosis (TB)-HIV Co-infected Patients on Efavirenz- or Dol NCT03982277 | Makerere University | Phase 2 |
| Unknown | Investigating Immune Responses to Aerosol BCG Challenge in Healthy UK Adults NCT03912207 | University of Oxford | Phase 1 |
| Terminated | Male Partner-assisted Contact Tracing for HIV and Tuberculosis in Malawi NCT04285905 | Liverpool School of Tropical Medicine | Phase 2 / Phase 3 |
| Completed | Mobile Health Intervention for Active Tuberculosis NCT03544476 | University of Washington | N/A |
| Unknown | Phase 1 Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Adolescent NCT03806699 | Quratis Inc. | Phase 1 |
| Completed | Digital Health Promotion in Iringa, Tanzania NCT03808597 | University of Oslo | N/A |
| Completed | An Early Bactericidal Activity, Safety and Tolerability of GSK3036656 in Subjects With Drug-sensitive Pulmonar NCT03557281 | GlaxoSmithKline | Phase 2 |
| Completed | Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia NCT03831906 | Institut National de la Santé Et de la Recherche Médicale, France | N/A |
| Completed | Multiplex PCR -Microarray-based Assay in the Detection of Mycobacterium NCT03794284 | Chinese University of Hong Kong | — |
| Completed | Accuracy and Consequences of Using Trial-of-antibiotics for TB Diagnosis (ACT-TB Study) NCT03545373 | London School of Hygiene and Tropical Medicine | Phase 3 |
| Completed | Dose-Defining Safety and Immunogenicity Study of MTBVAC in South African Neonates NCT03536117 | Biofabri, S.L | Phase 2 |
| Completed | Thin Bronchoscope and Virtual Bronchoscopic Navigation System for Tuberculosis NCT03802812 | Pusan National University Hospital | N/A |
| Completed | Contributing Factors for Poor HIV Treatment Response in Children With TB/HIV Coinfection NCT03800407 | University of Florida | — |
| Completed | Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents NCT03800394 | University of Florida | — |
| Completed | Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet NCT03800381 | University of Florida | — |
| Completed | ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039) NCT04121494 | François Spertini | EARLY_Phase 1 |
| Completed | A One-stop Shop for the Same Day Diagnosis and Management of TB and HIV NCT04043390 | Liverpool School of Tropical Medicine | N/A |
| Completed | Rapid and Accurate Diagnosis of Paediatric TB (RaPaed-AIDA-TB) NCT03734172 | Michael Hoelscher | — |
| Completed | A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults NCT03758612 | Global Alliance for TB Drug Development | Phase 1 |
| Unknown | Real-time Tuberculosis Medication Adherence Intervention in Rural Southwestern Uganda NCT03800888 | Mbarara University of Science and Technology | N/A |
| Completed | Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults NCT05283967 | University of Virginia | — |
| Unknown | The Effect of Latent Tuberculosis Infection on the Pregnancy Outcome of IVF-ET NCT04443283 | Peking University Third Hospital | — |
| Unknown | Innovation in Tuberculosis NCT04002869 | Fundació Institut Germans Trias i Pujol | — |